Influence of activated charcoal on the pharmacokinetics and the clinical features of carbamazepine poisoning

American Journal of Emergency Medicine

Volumn 24, Issue 4, 2006, Pages 440-443

  Brahmi, Nozha ^a   Kouraichi, Nadia ^a   Thabet, Hafedh ^a   Amamou, Mouldi ^a  

^a Centre d'Assistance Medicale Urgente   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; CARBAMAZEPINE;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INTOXICATION; EVALUATION; FEMALE; HALF LIFE TIME; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTICONVULSANTS; CARBAMAZEPINE; CHARCOAL; COMA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HALF-LIFE; HUMANS; LENGTH OF STAY; MALE; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL;

EID: 33745135439     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2005.12.025     Document Type: Article

References (13)

1. Low C., Haqqie S., Desai R., et al. Treatment of acute carbamazepine poisoning by hemoperfusion. Am J Emerg Med 14 (1996) 540-541
2. Perez A., and Wiley J.F. Pediatric carbamazepine suspension overdose-clinical manifestations and toxicokinetics. Pediatr Emerg Care 21 (2005) 252-254
3. Winnicka R., Lopacinski B., Szymczak W., et al. Carbamazepine poisoning: elimination kinetics and quantitative relationship with carbamazepine 10,11-epoxide. J Toxicol Clin Toxicol 40 (2002) 759-765
4. AAMT, and EAPCCT. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. J Toxicol Clin Toxicol 37 (1999) 731-751
5. Bertilsson L., and Tomson T. Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10,11-epoxide. An update. Clin Pharmacokinet 11 (1986) 177-198
6. Askenazi D., Goldstein S., Chang I.F., et al. Management of a severe carbamazepine overdose using albumin-enhanced continuous venovenous hemodialysis. Pediatrics 113 (2004) 406-409
7. Boldy D., Heath A., Ruddock S., et al. Activated charcoal for carbamazepine poisoning. Lancet 1 (1987) 1027
8. Montoya-Cabrera M.A., Sauceda-Garcia J.M., Escalante-Galindo P., et al. Carbamazepine poisoning in adolescent suicide attempters. Effectiveness of multiple-dose activated charcoal in enhancing carbamazepine elimination. Arch Med Res 27 (1996) 485-489
9. Hundt H.K.L., Aucamp A.K., and Müller F.O. Pharmacokinetic aspects of carbamazepine and its two major metabolites in plasma during overdosage. Hum Toxicol 2 (1983) 607-614
10. Vree T.B., Janssen T.J., Hekster Y.A., et al. Clinical Pharmacokinetics of carbamazepine and its epoxy and hydroxy metabolites in humans after an overdose. Ther Drug Monit 8 (1986) 297-304
11. Wason S., Baker R.C., Carolan P., et al. Carbamazepine overdose-the effects of multiple dose activated charcoal. J Toxicol Clin Toxicol 30 (1992) 39-48
12. Spiller H. Management of carbamazepine overdose. Pediatr Emerg Care 17 (2001) 452-456
13. Graudins A., Peden G., and Dowsett R.P. Massive overdose with controlled-release carbamazepine resulting in delayed peak serum concentrations and life-threatening toxicity. Emerg Med 14 (2002) 89-94